RESUMO
BACKGROUND: In the Netherlands, couples with unexplained infertility and a good prognosis to conceive spontaneously (i.e. Hunault > 30%) are advised to perform timed intercourse for at least another 6 months. If couples fail to conceive within this period, they will usually start assisted reproductive technology (ART). However, treatment of unexplained infertility by ART is empirical and can involve significant burdens. Intentional endometrial injury, also called 'endometrial scratching', has been proposed to positively affect the chance of embryo implantation in patients undergoing in vitro fertilization (IVF). It might also be beneficial for couples with unexplained infertility as defective endometrial receptivity may play a role in these women. The primary aim of this study is to determine whether endometrial scratching increases live birth rates in women with unexplained infertility. METHOD: A multicentre randomized controlled trial will be conducted in Dutch academic and non-academic hospitals starting from November 2017. A total of 792 women with unexplained infertility and a good prognosis for spontaneous conception < 12 months (Hunault > 30%) will be included, of whom half will undergo endometrial scratching in the luteal phase of the natural cycle. The women in the control group will not undergo endometrial scratching. According to Dutch guidelines, both groups will subsequently perform timed intercourse for at least 6 months. The primary endpoint is cumulative live birth rate. Secondary endpoints are clinical and ongoing pregnancy rate; miscarriage rate; biochemical pregnancy loss; multiple pregnancy rate; time to pregnancy; progression to intrauterine insemination (IUI) or IVF; pregnancy complications; complications of endometrial scratching; costs and endometrial tissue parameters associated with reproductive success or failure. The follow-up duration is 12 months. DISCUSSION: Several small studies show a possible beneficial effect of endometrial scratching in women with unexplained infertility trying to conceive naturally or through IUI. However, the quality of this evidence is very low, making it unclear whether these women will truly benefit from this procedure. The SCRaTCH-OFO trial aims to investigate the effect of endometrial scratching on live birth rate in women with unexplained infertility and a good prognosis for spontaneous conception < 12 months. TRIAL REGISTRATION: NTR6687 , registered August 31st, 2017. PROTOCOL VERSION: Version 2.6, November 14th, 2018.
Assuntos
Coeficiente de Natalidade , Endométrio/cirurgia , Infertilidade Feminina/terapia , Técnicas de Reprodução Assistida , Aborto Espontâneo , Adolescente , Adulto , Feminino , Humanos , Nascido Vivo , Fase Luteal , Estudos Multicêntricos como Assunto , Países Baixos , Prognóstico , Ensaios Clínicos Controlados Aleatórios como Assunto , Técnicas de Reprodução Assistida/economia , Adulto JovemRESUMO
BACKGROUND: Different screening strategies exist to estimate the risk of tubal factor subfertility, preceding laparoscopy. Three screening strategies, comprising Chlamydia trachomatis IgG antibody testing (CAT), high-sensitivity C-reactive protein (hs-CRP) testing and hysterosalpingography (HSG), were explored using laparoscopy as reference standard and the occurrence of a spontaneous pregnancy as a surrogate marker for the absence of tubal pathology. METHODS: In this observational study, 642 subfertile women, who underwent tubal testing, participated. Data on serological testing, HSG, laparoscopy and interval conception were collected. Multiple imputations were used to compensate for missing data. RESULTS: Strategy A (HSG) has limited value in estimating the risk of tubal pathology. Strategy B (CAT-->HSG) shows that CAT significantly discerns patients with a high versus low risk of tubal pathology, whereas HSG following CAT has no additional value. Strategy C (CAT-->hs-CRP-->HSG) demonstrates that hs-CRP may be valuable in CAT-positive patients only and HSG has no additional value. CONCLUSIONS: CAT is proposed as first screening test for tubal factor subfertility. In CAT-negative women, HSG may be performed because of its high specificity and fertility-enhancing effect. In CAT-positive women, hs-CRP seems promising, whereas HSG has no additional value. The position and timing of laparoscopy deserves critical reappraisal.
Assuntos
Doenças das Tubas Uterinas/diagnóstico , Infertilidade Feminina/diagnóstico , Adulto , Anticorpos Antibacterianos/análise , Proteína C-Reativa/análise , Infecções por Chlamydia/diagnóstico , Infecções por Chlamydia/imunologia , Chlamydia trachomatis/imunologia , Doenças das Tubas Uterinas/complicações , Doenças das Tubas Uterinas/diagnóstico por imagem , Feminino , Humanos , Histerossalpingografia , Infertilidade Feminina/diagnóstico por imagem , Infertilidade Feminina/etiologia , Valor Preditivo dos Testes , GravidezRESUMO
Chlamydia trachomatis is the most common sexually transmitted disease in the Netherlands. Acute chlamydia infections can be detected accurately by sensitive laboratory tests. However, in women, up to 70% ofchlamydia infections are asymptomatic and remain unnoticed and untreated. It is assumed that about lo% of all cervical infections ascend to the upper genital tract, where they can cause salpingitis, which may lead to tubal pathology. Following a chlamydia infection of the upper genital tract anti-chlamydia IgG antibodies are formed that may persist for a long time in serum. After it was shown that IgG positive women had tubal pathology more often than IgG negative women, the chlarnydia IgG antibody test (CAT) was introduced as a cheap, simple screening test to assess the risk oftubal pathology. undergo an expensive, invasive procedure i.e. a laparoscopy. The positive predictive value ofthe CAT is 58%, and as a consequence there will be many false positive test results. In the future, the positive predictive value of the CAT may be improved by adding markers of persistent infections. The negative predictive value of the CAT is 92%, from which can be concluded that the CAT is a good test to rule out tubal pathology.